KKR, Reddit, SpyGlass Pharma, and Veradermics saw huge insider buying in the past week, a bullish signal for their future ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...

These biotech companies have several catalysts ahead -- and in the past have soared on good news. They both offer innovative candidates that could result in game-changing treatments for patients. If ...

It's very tempting to pile into the stocks with the strongest positive momentum of the moment -- they've proven themselves and could continue along this path. But in many cases, you could set yourself ...

Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...

Eli Lilly will acquire Orna Therapeutics for up to $2.4 billion to gain access to the Watertown biotech's circular RNA ...

NKGen Biotech CEO Paul Song, M.D., is putting his money where his mouth is, investing $2.65 million of his own cash to help accelerate the cash-strapped biotech’s phase 2 Alzheimer’s disease cell ...